Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;15(4):271-6.
doi: 10.1007/s12603-011-0037-1.

The Five-Times-Sit-to-Stand test, a marker of global cognitive functioning among community-dwelling older women

C Annweiler  1 , A-M Schott, G Abellan van Kan, Y Rolland, H Blain, B Fantino, F R Herrmann, O Beauchet
Affiliations

The Five-Times-Sit-to-Stand test, a marker of global cognitive functioning among community-dwelling older women

C Annweiler et al. J Nutr Health Aging. 2011 Apr.

Abstract

Objective: To determine whether there was an association between the Five-Times-Sit-to-Stand test (FTSS) and the global cognitive function assessed with Short-Portable-Mental-State-Questionnaire (SPMSQ) among the EPIDOS cohort.

Design: Cross-sectional study corresponding to the baseline assessment of the EPIDOS study.

Setting: Five French cities including Amiens, Lyon, Montpellier, Paris and Toulouse.

Participants: 7421 community-dwelling older women (mean age 80.41 ± 0.04 years).

Measurements: Time to achieve FTSS, and SPMSQ score. Age, body mass index, high number of comorbidities, cardiovascular risk factors, depression, regular physical activity, joint pain, quadriceps strength, visual acuity, use of psychoactive drugs, serum albumin, vitamin D deficiency (i.e., serum concentration < 10 ng/mL), and the influence of seasons and study centers were used as covariables. Subjects were divided into 2 groups according to SPMSQ score (either impaired < 8/10 or normal ≥ 8/10).

Results: Compared to their counterparts, the women with cognitive impairment (n=1190, mean 81.51 ± 0.45 years) took more time in performing FTSS (17.8± 0.9 seconds versus 16.1 ± 0.3 seconds, P < 0.001). There was a significant negative association of SPMSQ score with FTSS (Unadjusted β=-0.02(95%CI -0.03;-0.01), P< 0.001; Fully Adjusted β=-0.03(95%CI -0.05;-0.01), P=0.003; Stepwise Backward Adjusted β=-0.02(95%CI -0.04;-0.01), P=0.005), as well as with advance in age (β=-0.04, P=0.006) and vitamin D deficiency (β=-0.34, P=0.011). The FTSS limit value in predicting moderate cognitive impairment was set at 15 seconds by a sensitivity analysis (negative predictive value=86%).

Conclusion: We found a negative association of FTSS with global cognitive performance. Achieving FTSS in less than 15 seconds made unlikely the existence of a moderate cognitive impairment. FTSS could be used as a tool in primary care medicine to exclude moderate cognitive decline.

PubMed Disclaimer

References

    1. Jorm A.F., Jolley D. The incidence of dementia: A meta-analysis. Neurology. 1998;51:728–733. 9748017. - PubMed
    1. French National Plan for “Alzheimer and related diseases” 2008–2012. http://www.plan-alzheimer.gouv.fr/mesures-en/sommaire_44_mesures.html. Accessed 26 April 2010.
    1. Iliffe S., Robinson L., Brayne C., Goodman C., Rait G., Manthorpe J., Ashley P., DeNDRoN Primary Care Clinical Studies Group Primary care and dementia: 1. diagnosis, screening and disclosure. Int J Geriatr Psychiatry. 2009;24:895–901. 10.1002/gps.2204 19226529. - DOI - PubMed
    1. Boustani M., Peterson B., Hanson L., Harris R., Lohr K.N., U.S. Preventive Services Task Force Screening for dementia in primary care: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003;138:927–937. 12779304. - PubMed
    1. Ashford J.W., Borson S., O'Hara R., Dash P., Frank L., Robert P., Shankle W.R., Tierney M.C., Brodaty H., Schmitt F.A., Kraemer H.C., Buschke H., Fillit H. Should older adults be screened for dementia? It is important to screen for evidence of dementia! Alzheimer Dement. 2007;3:75–80. 10.1016/j.jalz.2007.03.005 - DOI - PMC - PubMed

Publication types